Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome
- PMID: 15158632
- PMCID: PMC7112423
- DOI: 10.1016/S0140-6736(04)16255-7
Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome
Abstract
Severe acute respiratory syndrome (SARS) is thought to be caused by a novel coronavirus, SARS-associated coronavirus. We studied viral shedding of SARS coronavirus to improve diagnosis and infection control. Reverse-transcriptase PCR was done on 2134 specimens of different types. 355 (45%) specimens of nasopharyngeal aspirates and 150 (28%) of faeces were positive for SARS coronavirus RNA. Positive rates peaked at 6-11 days after onset of illness for nasopharyngeal aspirates (87 of 149 [58%], to 37 of 62 [60%]), and 9-14 days for faeces (15 of 22 [68%], to 26 of 37 [70%]). Overall, peak viral loads were reached at 12-14 days of illness when patients were probably in hospital care, which would explain why hospital workers were prone to infection. Low rate of viral shedding in the first few days of illness meant that early isolation measures would probably be effective.
Similar articles
-
Nasopharyngeal detection of severe acute respiratory syndrome-associated coronavirus RNA in health-care workers.Chest. 2006 Jan;129(1):12-3. doi: 10.1378/chest.129.1.12. Chest. 2006. PMID: 16424407 Free PMC article. No abstract available.
-
Colonization of severe acute respiratory syndrome-associated coronavirus among health-care workers screened by nasopharyngeal swab.Chest. 2006 Jan;129(1):95-101. doi: 10.1378/chest.129.1.95. Chest. 2006. PMID: 16424418 Free PMC article.
-
Severe acute respiratory syndrome-associated coronavirus in lung tissue.Emerg Infect Dis. 2004 Jan;10(1):20-4. doi: 10.3201/eid1001.030404. Emerg Infect Dis. 2004. PMID: 15078592 Free PMC article.
-
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.Curr Opin Pulm Med. 2014 May;20(3):233-41. doi: 10.1097/MCP.0000000000000046. Curr Opin Pulm Med. 2014. PMID: 24626235 Review.
-
Severe acute respiratory syndrome: global initiatives for disease diagnosis.QJM. 2003 Nov;96(11):845-52. doi: 10.1093/qjmed/hcg146. QJM. 2003. PMID: 14566040 Free PMC article. Review.
Cited by
-
Wastewater based epidemiology as a surveillance tool during the current COVID-19 pandemic on a college campus (East Carolina University) and its accuracy in predicting SARS-CoV-2 outbreaks in dormitories.PLoS One. 2024 Apr 18;19(4):e0289906. doi: 10.1371/journal.pone.0289906. eCollection 2024. PLoS One. 2024. PMID: 38635813 Free PMC article.
-
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database.Front Pharmacol. 2023 Dec 21;14:1320458. doi: 10.3389/fphar.2023.1320458. eCollection 2023. Front Pharmacol. 2023. PMID: 38186645 Free PMC article.
-
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond.Clin Microbiol Rev. 2024 Mar 14;37(1):e0010322. doi: 10.1128/cmr.00103-22. Epub 2023 Dec 14. Clin Microbiol Rev. 2024. PMID: 38095438 Review.
-
COVID-19-induced gastrointestinal autonomic dysfunction: A systematic review.World J Clin Cases. 2023 Aug 6;11(22):5252-5272. doi: 10.12998/wjcc.v11.i22.5252. World J Clin Cases. 2023. PMID: 37621592 Free PMC article.
-
Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors.Biomed Pharmacother. 2023 Feb;158:114213. doi: 10.1016/j.biopha.2023.114213. Epub 2023 Jan 3. Biomed Pharmacother. 2023. PMID: 36916436 Free PMC article.
References
-
- WHO Severe acute respiratory syndrome (SARS): multi-country outbreak—update 34. http://www.who.int/csr/don/2003_04_19/en/ (accessed March 22, 2004).
-
- WHO Case definitions for surveillance of severe acute respiratory syndrome (SARS) http://www.who.int/csr/sars/casedefinition/en/ (accessed March 22, 2004).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous